View from Brussels

Nov 01, 2018
Applied Clinical Trials
Policy discussions include focus on targeted treatments on one side and wider access and prevention-over-treatment on the other.
Oct 01, 2018
Applied Clinical Trials
A new report on EU's digital health strategy also calls for closer coordination of national HTA arrangements—but both policy initiatives couldn't be more different.
Sep 01, 2018
Applied Clinical Trials
Peter O’Donnell gauges the impact of FDA guidance on igniting the adaptive pathways debate in Europe.
Jul 01, 2018
Applied Clinical Trials
Recent developments offer more clues to the EU’s seemingly less-than-serious approach to health policy formation.
Jun 01, 2018
Applied Clinical Trials
Peter O’Donnell explores the convergence of policy and science in new vaccine R&D pursuits in Europe.
Apr 01, 2018
Applied Clinical Trials
Relocating the European Medicines Agency was always going to be hard—but no-one ever expected it to degenerate into farce.
Mar 01, 2018
Applied Clinical Trials
Peter O’Donnell weighs the varying views in Europe on the risks of going the adaptive pathways route for drug approval.
Feb 01, 2018
Applied Clinical Trials
Peter O’Donnell looks at efforts in Europe to improve R&D communication and trust with investors and the public.
Dec 01, 2017
Applied Clinical Trials
With the literal toss of a coin officially sending the EMA to Amsterdam post-Brexit, it's worth reflecting on what might have been if the decision went differently.
Oct 01, 2017
Applied Clinical Trials
New safety review of epilespy treatment puts spotlight on issues such as communication between regulators and prescribers.
native1_300x100
lorem ipsum